Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

175

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03DC03	LEUKOTRIS	G	Montelukast - 10mg	10mg	Tablet	981,645 L.L
R03DC03	LUKAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	978,317 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	1,136,296 L.L
R03DC03	MOTRINEX	G	Montelukast - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	844,701 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	228,453 L.L
R03DC03	UNICAST	G	Montelukast (sodium) - 10mg	10mg	Tablet, film coated	802,274 L.L
R03DC03	SINGULAIR PEDIATRIC	B	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,217,521 L.L
R03DC03	LUKAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	783,460 L.L
R03DC03	MONTELUKAST ARROW LAB	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	851,996 L.L
R03DC03	MONTELUKAST-SANDOZ	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,184,140 L.L
R03DC03	RELIEFAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	1,034,119 L.L
R03DC03	ROMILAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, mouth dissolving	405,840 L.L
R03DC03	UNICAST	G	Montelukast (sodium) - 4mg	4mg	Tablet, chewable	783,460 L.L
R03DC03	SINGULAIR PAEDIATRIC	B	Montelukast (sodium) - 4mg	4mg	Granules	1,248,430 L.L
R03DC03	AIRFAST PEDIATRICS	G	Montelukast (sodium) - 4mg	4mg	Granules for solution	880,217 L.L
R03DC03	LEUKOTRIS	G	Montelukast - 5mg	5mg	Tablet	979,085 L.L
R03DC03	LEUKOTRIS	G	Montelukast - 4mg	4mg	Tablet	783,268 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable lyophilised powder for solution+diluent	54,613,625 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 150mg	150mg	Injectable solution	37,110,724 L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	L.L
R03DX10	FASENRA	B	Benralizumab - 30mg	30mg	Injectable solution	214,213,273 L.L
R05	COQUELUSEDAL NOURRISSON	G	Grindelia extract - 10mg, Gelsenium extract - 5mg		Suppository	515,819 L.L
R05	EXALL FORTE	G	Chlorpheniramine maleate - 2.5mg, Guaifenesin - 100mg, Acetaminophen - 100mg, Diprophylline - 25mg		Syrup	501,701 L.L
R05	COQUELUSEDAL ENFANT	G	Grindelia extract - 20mg, Gelsenium extract - 10mg		Suppository	598,051 L.L
R05C	PULMONAL SIROP	G	Belladona tincture - 0.5g/5ml, Drosera tincture - 2g/5ml, Ammonium bromide - 2g/5ml, Sodium benzoate - 2g/5ml		Syrup	148,463 L.L
R05C	SULDEX	G	Caffein anyhdrous - 0.216g, Antipyrine - 0.972g, Potassium sulfaguaiacolate - 1.44g		Syrup	152,302 L.L
R05CA	ASPECTON COUGH SYRUP	G	Thyme soft extract - 6.69g/100ml		Syrup	588,603 L.L

...

175

...